FMP
Silexion Therapeutics LTD
SLXN
NASDAQ
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
0.81 USD
-0.0139 (-1.72%)
Historical Prices
From:
To:
Date
Open
Low
High
Close
Volume
Change
Change %
2025-04-11 09:30:00
0.85
0.85
0.85
0.85
0
-
-
2025-04-11 09:32:00
0.85
0.85
0.85
0.85
241
0
0
2025-04-11 09:39:00
0.83
0.82
0.83
0.82
10k
-0.03
-3.06
2025-04-11 09:40:00
0.81
0.81
0.81
0.81
583
-0.01
-1.71
2025-04-11 09:41:00
0.83
0.83
0.83
0.83
223
0.02
3.07
2025-04-11 09:45:00
0.84
0.84
0.84
0.84
235
0.01
0.62
2025-04-11 09:46:00
0.86
0.86
0.86
0.86
200
0.02
2.38
2025-04-11 09:50:00
0.83
0.83
0.83
0.83
644
-0.03
-3.45
2025-04-11 09:53:00
0.86
0.86
0.86
0.86
5.08k
0.03
3.56
2025-04-11 09:54:00
0.83
0.83
0.83
0.83
1.02k
-0.03
-3.48
2025-04-11 10:13:00
0.83
0.83
0.83
0.83
1.09k
0
0
2025-04-11 10:22:00
0.81
0.81
0.81
0.81
176
-0.02
-2.4
2025-04-11 10:32:00
0.82
0.82
0.82
0.82
3.52k
0.01
1.22
2025-04-11 10:38:00
0.82
0.82
0.82
0.82
500
0
0
2025-04-11 10:42:00
0.82
0.82
0.82
0.82
3.5k
0
0
2025-04-11 10:45:00
0.82
0.81
0.82
0.81
0
-0.01
-1.21
2025-04-11 11:09:00
0.81
0.81
0.81
0.81
0
0
0.23
2025-04-11 11:23:00
0.81
0.81
0.81
0.81
61
0
0
2025-04-11 11:24:00
0.81
0.81
0.81
0.81
745
-0
-0.25
